Theravance Biopharma, Inc. (FRA:0TB)
Germany · Delayed Price · Currency is EUR 17.10
+0.10 (0.59%)
At close: Nov 28, 2025
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of €854.77 million as of December 1, 2025. Its market cap has increased by 108.06% in one year.
Market Cap
854.77M
Enterprise Value
606.93M
Revenue
68.46M
Ranking
n/a
PE Ratio
34.18
Stock Price
€17.10
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from 16.00 to 854.77M, an increase of 5,342,306,257.47%. That is a compound annual growth rate of 367.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 887.11M | 98.48% |
| Dec 31, 2024 | 446.95M | -11.74% |
| Dec 29, 2023 | 506.39M | -28.28% |
| Dec 30, 2022 | 706.03M | -1.40% |
| Dec 31, 2021 | 716.07M | -22.96% |
| Dec 31, 2020 | 929.45M | -29.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |